What Drs. Geier say ... in rebuttal to Quacks Gorski & Probert

(please don't believe the lies of the Quack Ratbags Team (Probert, Gorski,
etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.





*** Posted via a free Usenet account from http://www.teranews.com ***

Ilena Rose wrote:
(please don't believe the lies of the Quack Ratbags Team (Probert, Gorski,
etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

None of this rebuts anything posted by Orac or me.

"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert, Gorski,
etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

Why do you find his studies more believable than the studies that contradict
him?

"Skeptic" wrote in message
news:RdMbg.157689$oL.52564@attbi_s71...

"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert,
Gorski, etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

Why do you find his studies more believable than the studies that
contradict him?


Here are other viewpoints on the work of Dr. Geier ...


http://www.answers.com/topic/mark-geier


Mark Geier


Mark R. Geier, MD, PhD, (b. 1948, Washington, D.C.) is a medical
doctor based in Silver Spring, Maryland, who also holds a doctorate in
genetics and is board-certified in medical genetics and forensic
medicine. He was a researcher at the National Institutes of Health for
ten years and previously was a professor at Johns Hopkins University.
He has studied vaccines for more than 30 years and has published over
50 peer-reviewed papers on vaccine safety, efficacy, contamination and
policy. In 1970, while at the National Institutes of Health, Dr. Geier
co-authored a paper published in Nature reporting the first sucessful
genetic engineering experiment in which bacteriophage Lambda which
carried the galactose operon was used to correct the inability of
cells in tissue culture from a patient with galactosemia to metabolise
the milk sugar galactose. This work received world-wide aclaim in the
scientific press and in the news media and resulted in a personal call
of congratulation from then President Richard Nixon. In 1973 Dr. Geier
was an author of another paper in the Nature which reported the
spleen, which was thought to be mostly vestigual in humans, in fact
played a critical role in immunity by maintaining intact antigen
allowing for a more robust immune response which was especially
important the vaccination process. Dr Geier was a co-author on a paper
in the New England Journal of Medicine which futher discussed and
extended the observations on the critical role that the spleen plays
in response to vaccines and other immune challenges. In 1973, Dr.
Geier after having been part of the group that discovered that there
was widespread bacterial virus contamination in US vaccines, presented
a paper "A model system for the evaluation of the fate of phage in
contaminated vaccines: Physiologic disposition of bacteriophage in
mice." at the Proceedings of the Workshop of Problems of Phage
Contamination FDA. In 1978 Dr. Geier published a study "Endotoxins in
commercial vaccine." in Applied and Environmental Microbiology which
found high levels of endotoxin in commercial vaccines especailly in
whole cell Diptheria, Tetanus, Pertussis (DTP) vaccine. Following this
paper, Dr. Geier worked for many years to help convince the public
health authorities to switch from whole cell DTP to the much safer
DTaP which contained a highly purified form of Pertussis vaccine. In
1991 the Institute of Medicine of the National Academy of
Sciences,(IOM) invited Dr. Geier to address them on the toxins
contained in DTP vaccine and the expected time frame over which they
could be expected to work. Dr. Geier presented evidence to the IOM
that the expected time of vulnerability was seven days. In 1993 the
IOM published that the evidence was compatible whole Pertussis vaccine
causing permanent brain damage in otherwise apparently health children
if the first symptoms of neurological damage occurred in the first
seven days following the vaccination. The US began to switch to the
far safer DTaP in 1993 and as of 2002 the US no longer used any whole
cell DTP vaccine.


Career
Dr. Geier wrote the article, The True Story of Pertussis Vaccination:
A Sordid Legacy? which won the first annual Stanley W. Jackson award
for the best paper published in the Journal of the History of Medicine
and Allied Sciences during the period of 2000 to 2002. He has authored
over 90 publications.


Geier has made several presentations to the Institute of Medicine
(IOM) on the adverse effects of vaccinations. He and his son, David
Geier, are the only independent researchers ever to have been
permitted to study the Vaccine Safety Datalink (VSD) database of the
Centers for Disease Control (CDC).


Geier has testified before the US House of Representatives Committee
on Government Reform Investigating Vaccines and the Autism Epidemic,
to critique the Hviid study, conducted in Denmark on autism and
thimerosal exposure, and he has also addressed the Food and Drug
Administration (FDA) Advisory Committee regarding vaccine safety. He
has testified as an expert witness in about 100 cases before the
National Vaccine Injury Compensation Program in the US Court of
Federal Claims. Dr. Geier and his son have been invited to speak to
many state houses who were or are considering state wide bans on
Thimerosal containing vaccines.


Geier has published several scientific reports, with his son David
Geier, showing a relation between mercury exposure during infancy and
the onset of neurodevelopmental disorders. Geier has suggested his
research shows a direct causal link between Thimerosal containing
vaccines (TCVs) and the onset of neurological disorders, including
autism.


Controversial studies
Geier and his son have published six studies on the possible link
between autistic spectrum disorders and TCVs. In their first study,
they compared the number of complaints associated with TCVs,
administered between 1992 and 2000, to the number of complaints
resulting from a thimerosal-free vaccine administered between 1997 and
2000. The children who received greater amounts of ethylmercury from
TCVs were more likely to have a complaint filed with the Vaccine
Adverse Event Reporting System (VAERS). Further studies by the Geiers
yielded similar results.


US health agencies have uniformly rejected the conclusions of the
Geiers' studies, and one of the Geiers' articles was the subject of
heavy criticism by the American Academy of Pediatrics On the other
hand, Mercury in Medicine Taking Unnecessary Risks, a report prepared
by the staff of the Subcommittee on Human Rights and Wellness,
Committee on Government Reform United States House of Representatives
Chaired by Dan Burton published in the Congression Register in May of
2003 stated: However, the Committee upon a thorough review of the
scientific literature and internal documents from government and
industry did find evidence that thimerosal did pose a risk. Thimerosal
used as a preservative in vaccines is likely related to the autism
epidemic. This epidemic in all probability may have been prevented or
curtailed had the FDA not been asleep at the switch regarding the lack
of safety data regarding injected thimerosal and the sharp rise of
infant exposure to this known neurotoxin. Our public health agencies'
failure to act is indicative of institutional malfeasance for
self-protection and misplaced protectionism of the pharmaceutical
industry." [1]. Geier says public health officials are "just trying to
cover it up."


Limited access to Vaccine Safety Datalink records
On February 17, 2004, a panel of medical experts was assembled by the
Institute of Medicine (IOM), an arm of the National Academy of
Sciences. The panel recommended the CDC ease its restrictions on
outside scientists seeking access to its strictly confidential Vaccine
Safety Datalink, containing over seven million records including
reports of suspected adverse reactions to vaccines.


The Geiers have been granted access to this data [2], but the National
Immunization Program found that "In summary, during the first visit
the researchers conducted unapproved analysis on their datasets and on
the second visit attempted to carry out unapproved analyses but did
not complete this attempt. This analysis, had it been completed, could
have increased the risk of a confidentiality breach. Before leaving,
the researchers renamed files for removal which were not allowed to be
removed. Had it gone undetected, this would have constituted a breach
of the rules about confidentiality."[3]


Chelation research
Geier has also published studies which, he says, indicate children
diagnosed with autism excrete more mercury upon chelation than control
subjects. Many of these children are reported as having tests showing
amounts of mercury excreted several times the normal levels. Chelation
therapy is conventionally used only to treat heavy metal poisoning,
and carries the risk of overly reducing the levels of beneficial
metals in the body, such as calcium. In 2004 Dr. Geier and his son
published a paper in Medical Hypotheses, a non-peer-reviewed journal,
on the potential importance of lowering testosterone as part of the
treatment of autism spectum disorders and other disorders which they
claim involve mercury toxicity.


An advocate for vaccine safety
Geier has supported efforts by Representatives Dave Weldon, MD, Dan
Burton, and Carolyn Maloney, to pass legislation introduced in early
2005 to ban the use of mercury based preservatives (i.e., thimerosal)
in vaccines in the United States. Although mercury preservatives have
been removed or reduced from some vaccines in the US, several vaccines
and most US influenza vaccines still contain the full dose of
Thimerosal. Geier said in an interview that the link between
thimerosal and autism was clear.


An NBC crew filmed a presentation by the Geiers before the network's
Autism: The Hidden Epidemic?[4] series in February, 2005, but the
producers chose not to use the material.


Credibility as expert witness questioned
Geier and his son David also serve regularly as expert witnesses for
parents seeking compensation from the National Vaccine Injury
Compensation Program for vaccine injuries to their children. Geier has
been criticized over his qualifications in these hearings, wherein one
Special Master labeled him "a professional witness" who "clearly lacks
the expertise" required. [5] Critics of the vaccine injury
compensation system question the stringency of the requirements, which
they contend effectively preclude fair presentation in the hearings of
testimony from their experts.


On at least ten separate occasions, the Special Master ruled that
Geier lacked the necessary qualifications or board-certification to
offer an expert opinion. Litigants pressing vaccine injury claims have
a dual challenge, since relatively few experts in relevant fields
think thimerosal causes autism, and even fewer work in specialties
required by the Vaccine Injury Compensation Program.


However, on November 25, 2003, Special Master French praised Geier's
credentials and vast experience and said Dr. Geier "ranks high among
those who have studied vaccine issues through the medical literature
on vaccines, databases, studies, articles and information on vaccine
safety and efficacy in vaccine policy. The tenor of his testimony in
this case addressed the importance of statistical databases in
providing statistical reliability and validity in interpreting the
epidemiology and issues relating to autism and various vaccines...Dr.
Geier has recently proposed a data-sharing process that would improve
the reliability of present statistical data that would include the
present VAERS statistical database. It would be helpful in
interpreting the epidemiology and issues relating to the autism
controversy." [6]


Background
Education:


1970 - B.S. George Washington University, Washington, D.C.
1970-1971 - Graduate Student; Department of Human Genetics and
Development, Columbia University, New York, New York
1973 - Ph.D. Genetics, George Washington University, Washington, D.C.
1978 - M.D. George Washington University, Washington, D.C.
Work Experience:


1969-1970 - Research (Student) at the National Institutes for Health,
Bethesda, MD
1970-1971 - NIH Traineeship at Columbia University, Department of
Human Genetics and Development, New York, NY
1971-1973 - Research Geneticist, Laboratory of General and Comparative
Biochemistry, National Institute of Mental Health (NIMH), National
Institutes of Health (NIH), Bethesda, Maryland
1973-1974 - Staff Fellow, Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1974-1978 - On Professional Staff Laboratory of General and
Comparative Biochemistry NIMH, NIH, Bethesda, MD
1978-1979 - Intern and Fellow, Department of Obstetrics and
Gynecology, the Johns Hopkins Hospital, Baltimore, Maryland
1979-1982 - Assistant Professor, Department of Gynecology and
Obstetrics, the Johns Hopkins School of Medicine, Baltimore, MD
1980-1982 - Guest worker Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1981-1984 - Assistant Research Professor, Psychiatry Department,
Uniformed School of the Health Sciences, Bethesda, MD
1988-1994 - Director of Genetics of Maryland Medical Laboratory, Inc.
Baltimore, MD
1989-1994 - Member of the Substance Abuse and Doping Committee and the
Sports Medicine and Science Committee of the United States Bobsled and
Skeleton Federation (Olympic Committee)
Board Certification:


1987 - American Board of Medical Genetics
1993 - Associate Founding Member of the American College of Medical
Genetics
1996 - Board Certified by the American Board of Forensic Examiners
1996 - Diplomate of the American Board of Forensic Medicine
Other Positions:


1980-2003 - Laboratory Director, Molecular Medicine, MD
1980-Present - Co-director of Genetic Consultants, Bethesda, MD
1981-Present - Director of Institute of Immuno-Oncology and Genetics,
MD
1986-Present - President of Genetic Counseling and Research, Inc., T/A
The Genetic Center, Baltimore, MD
1997-Present - President of Genetic Counseling and Research, Inc. T/A
The Ultrasound Institute of Baltimore
1997-Present - President of the Genetic Centers of America
2001 - Host of one hour weekly medical talk show "The Dr. Mark Geier
Show" on KFNX in Phoenix, Arizona, WALE in Provident, Rhode Island,
and on the World Wide Web.
Journal Peer-Reviewer:


Annals of Internal Medicine
Clinical and Experimental Rheumatology
Environmental Health Perspectives
Expert Review of Vaccines
Expert Opinion on Emerging Drugs
Vaccine
Major Presentations:


Addressed United States' State Department, Foreign Service Institute
(Washington, DC) on Contemporary Genetics
Addressed the Institute of Medicine of the U.S. National Academy of
Sciences (Washington, DC) on Vaccine Safety & Vaccine Policy Issues
Addressed the Government Reform Committee of the United States' House
of Representatives (Washington, DC) on Vaccine Safety Issues
Addressed the Food and Drug Administration's Vaccine Advisory
Committee (Silver Spring, MD) on Vaccine Safety Issues


See also
Controversies in autism
Vaccination critics


References
JPandS.org (pdf) - 'Thimerosal in Childhood Vaccines, Neurodevelopment
Disorders and Heart Disease in the United States', Mark and David
Geier, Journal of American Physicians and Surgeons, vol 8, no 1,
Spring, 2003
JPandS.org (pdf) - 'A Case-Control Study of Mercury Burden in Children
with Autistic Spectrum Disorders', Jeff Bradstreet, MD, David A.
Geier, BA, Jerold J. Kartzinel, MD, James B. Adams, PhD, Mark R.
Geier, MD, PhD Journal of American Physicians and Surgeons, vol 8, no
3, Summer, 2003
MedSciMonit.com (pdf) - 'A two-phased population epidemiological study
of the safety of thimerosal-containing vaccines: a follow up
analysis', David A. Geier and Mark R. Geier, Med Sci Monit, vol 11, no
4, April 1, 2005


External links
IOM.edu - 'Immunization Safety Review: Vaccines and Autism', US
Institute of Medicine (May 17, 2004)
MomsAgainstMercury.org - 'A Shot in the Dark: Doctors Question Flu
Shot Statistics', Kelly O'Meara (2004)
MomsOnAMissionForAutism.org - Letter from Congressman Dave Weldon,
M.D., to the CDC
UniversityOfHealth.net - 'Institute of Medicine Report Stuns
Scientific Community and Parents: Report Says No Evidence Mercury In
Vaccines Related To Epidemic Levels of Autism' (May 20, 2004)

"Jan Drew" wrote in message
t...

"Skeptic" wrote in message
news:RdMbg.157689$oL.52564@attbi_s71...

"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert,
Gorski, etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

Why do you find his studies more believable than the studies that
contradict him?


Here are other viewpoints on the work of Dr. Geier ...

So I will extend the same question to you as I did to Ilena - why do you
find the studies by Geier more believable the studies that contradict his
work? Do you give the criticism of his most discussed study any weight...
that he had incorrect facts, that his study design was poor, and that his
conclusions were inaccurate? Or do you just ignore these or shrug them off?

"Skeptic" wrote in message
news:8CZbg.955332$x96.369049@attbi_s72...

"Jan Drew" wrote in message
t...

"Skeptic" wrote in message
news:RdMbg.157689$oL.52564@attbi_s71...

"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert,
Gorski, etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

Why do you find his studies more believable than the studies that
contradict him?


Here are other viewpoints on the work of Dr. Geier ...

So I will extend the same question to you as I did to Ilena - why do you
find the studies by Geier more believable the studies that contradict his
work? Do you give the criticism of his most discussed study any weight...
that he had incorrect facts, that his study design was poor, and that his
conclusions were inaccurate? Or do you just ignore these or shrug them
off?

http://www.answers.com/topic/mark-geier


Mark Geier


Mark R. Geier, MD, PhD, (b. 1948, Washington, D.C.) is a medical
doctor based in Silver Spring, Maryland, who also holds a doctorate in
genetics and is board-certified in medical genetics and forensic
medicine. He was a researcher at the National Institutes of Health for
ten years and previously was a professor at Johns Hopkins University.
He has studied vaccines for more than 30 years and has published over
50 peer-reviewed papers on vaccine safety, efficacy, contamination and
policy. In 1970, while at the National Institutes of Health, Dr. Geier
co-authored a paper published in Nature reporting the first sucessful
genetic engineering experiment in which bacteriophage Lambda which
carried the galactose operon was used to correct the inability of
cells in tissue culture from a patient with galactosemia to metabolise
the milk sugar galactose. This work received world-wide aclaim in the
scientific press and in the news media and resulted in a personal call
of congratulation from then President Richard Nixon. In 1973 Dr. Geier
was an author of another paper in the Nature which reported the
spleen, which was thought to be mostly vestigual in humans, in fact
played a critical role in immunity by maintaining intact antigen
allowing for a more robust immune response which was especially
important the vaccination process. Dr Geier was a co-author on a paper
in the New England Journal of Medicine which futher discussed and
extended the observations on the critical role that the spleen plays
in response to vaccines and other immune challenges. In 1973, Dr.
Geier after having been part of the group that discovered that there
was widespread bacterial virus contamination in US vaccines, presented
a paper "A model system for the evaluation of the fate of phage in
contaminated vaccines: Physiologic disposition of bacteriophage in
mice." at the Proceedings of the Workshop of Problems of Phage
Contamination FDA. In 1978 Dr. Geier published a study "Endotoxins in
commercial vaccine." in Applied and Environmental Microbiology which
found high levels of endotoxin in commercial vaccines especailly in
whole cell Diptheria, Tetanus, Pertussis (DTP) vaccine. Following this
paper, Dr. Geier worked for many years to help convince the public
health authorities to switch from whole cell DTP to the much safer
DTaP which contained a highly purified form of Pertussis vaccine. In
1991 the Institute of Medicine of the National Academy of
Sciences,(IOM) invited Dr. Geier to address them on the toxins
contained in DTP vaccine and the expected time frame over which they
could be expected to work. Dr. Geier presented evidence to the IOM
that the expected time of vulnerability was seven days. In 1993 the
IOM published that the evidence was compatible whole Pertussis vaccine
causing permanent brain damage in otherwise apparently health children
if the first symptoms of neurological damage occurred in the first
seven days following the vaccination. The US began to switch to the
far safer DTaP in 1993 and as of 2002 the US no longer used any whole
cell DTP vaccine.


Career
Dr. Geier wrote the article, The True Story of Pertussis Vaccination:
A Sordid Legacy? which won the first annual Stanley W. Jackson award
for the best paper published in the Journal of the History of Medicine
and Allied Sciences during the period of 2000 to 2002. He has authored
over 90 publications.


Geier has made several presentations to the Institute of Medicine
(IOM) on the adverse effects of vaccinations. He and his son, David
Geier, are the only independent researchers ever to have been
permitted to study the Vaccine Safety Datalink (VSD) database of the
Centers for Disease Control (CDC).


Geier has testified before the US House of Representatives Committee
on Government Reform Investigating Vaccines and the Autism Epidemic,
to critique the Hviid study, conducted in Denmark on autism and
thimerosal exposure, and he has also addressed the Food and Drug
Administration (FDA) Advisory Committee regarding vaccine safety. He
has testified as an expert witness in about 100 cases before the
National Vaccine Injury Compensation Program in the US Court of
Federal Claims. Dr. Geier and his son have been invited to speak to
many state houses who were or are considering state wide bans on
Thimerosal containing vaccines.


Geier has published several scientific reports, with his son David
Geier, showing a relation between mercury exposure during infancy and
the onset of neurodevelopmental disorders. Geier has suggested his
research shows a direct causal link between Thimerosal containing
vaccines (TCVs) and the onset of neurological disorders, including
autism.


Controversial studies
Geier and his son have published six studies on the possible link
between autistic spectrum disorders and TCVs. In their first study,
they compared the number of complaints associated with TCVs,
administered between 1992 and 2000, to the number of complaints
resulting from a thimerosal-free vaccine administered between 1997 and
2000. The children who received greater amounts of ethylmercury from
TCVs were more likely to have a complaint filed with the Vaccine
Adverse Event Reporting System (VAERS). Further studies by the Geiers
yielded similar results.


US health agencies have uniformly rejected the conclusions of the
Geiers' studies, and one of the Geiers' articles was the subject of
heavy criticism by the American Academy of Pediatrics On the other
hand, Mercury in Medicine Taking Unnecessary Risks, a report prepared
by the staff of the Subcommittee on Human Rights and Wellness,
Committee on Government Reform United States House of Representatives
Chaired by Dan Burton published in the Congression Register in May of
2003 stated: However, the Committee upon a thorough review of the
scientific literature and internal documents from government and
industry did find evidence that thimerosal did pose a risk. Thimerosal
used as a preservative in vaccines is likely related to the autism
epidemic. This epidemic in all probability may have been prevented or
curtailed had the FDA not been asleep at the switch regarding the lack
of safety data regarding injected thimerosal and the sharp rise of
infant exposure to this known neurotoxin. Our public health agencies'
failure to act is indicative of institutional malfeasance for
self-protection and misplaced protectionism of the pharmaceutical
industry." [1]. Geier says public health officials are "just trying to
cover it up."


Limited access to Vaccine Safety Datalink records
On February 17, 2004, a panel of medical experts was assembled by the
Institute of Medicine (IOM), an arm of the National Academy of
Sciences. The panel recommended the CDC ease its restrictions on
outside scientists seeking access to its strictly confidential Vaccine
Safety Datalink, containing over seven million records including
reports of suspected adverse reactions to vaccines.


The Geiers have been granted access to this data [2], but the National
Immunization Program found that "In summary, during the first visit
the researchers conducted unapproved analysis on their datasets and on
the second visit attempted to carry out unapproved analyses but did
not complete this attempt. This analysis, had it been completed, could
have increased the risk of a confidentiality breach. Before leaving,
the researchers renamed files for removal which were not allowed to be
removed. Had it gone undetected, this would have constituted a breach
of the rules about confidentiality."[3]


Chelation research
Geier has also published studies which, he says, indicate children
diagnosed with autism excrete more mercury upon chelation than control
subjects. Many of these children are reported as having tests showing
amounts of mercury excreted several times the normal levels. Chelation
therapy is conventionally used only to treat heavy metal poisoning,
and carries the risk of overly reducing the levels of beneficial
metals in the body, such as calcium. In 2004 Dr. Geier and his son
published a paper in Medical Hypotheses, a non-peer-reviewed journal,
on the potential importance of lowering testosterone as part of the
treatment of autism spectum disorders and other disorders which they
claim involve mercury toxicity.


An advocate for vaccine safety
Geier has supported efforts by Representatives Dave Weldon, MD, Dan
Burton, and Carolyn Maloney, to pass legislation introduced in early
2005 to ban the use of mercury based preservatives (i.e., thimerosal)
in vaccines in the United States. Although mercury preservatives have
been removed or reduced from some vaccines in the US, several vaccines
and most US influenza vaccines still contain the full dose of
Thimerosal. Geier said in an interview that the link between
thimerosal and autism was clear.


An NBC crew filmed a presentation by the Geiers before the network's
Autism: The Hidden Epidemic?[4] series in February, 2005, but the
producers chose not to use the material.


Credibility as expert witness questioned
Geier and his son David also serve regularly as expert witnesses for
parents seeking compensation from the National Vaccine Injury
Compensation Program for vaccine injuries to their children. Geier has
been criticized over his qualifications in these hearings, wherein one
Special Master labeled him "a professional witness" who "clearly lacks
the expertise" required. [5] Critics of the vaccine injury
compensation system question the stringency of the requirements, which
they contend effectively preclude fair presentation in the hearings of
testimony from their experts.


On at least ten separate occasions, the Special Master ruled that
Geier lacked the necessary qualifications or board-certification to
offer an expert opinion. Litigants pressing vaccine injury claims have
a dual challenge, since relatively few experts in relevant fields
think thimerosal causes autism, and even fewer work in specialties
required by the Vaccine Injury Compensation Program.


However, on November 25, 2003, Special Master French praised Geier's
credentials and vast experience and said Dr. Geier "ranks high among
those who have studied vaccine issues through the medical literature
on vaccines, databases, studies, articles and information on vaccine
safety and efficacy in vaccine policy. The tenor of his testimony in
this case addressed the importance of statistical databases in
providing statistical reliability and validity in interpreting the
epidemiology and issues relating to autism and various vaccines...Dr.
Geier has recently proposed a data-sharing process that would improve
the reliability of present statistical data that would include the
present VAERS statistical database. It would be helpful in
interpreting the epidemiology and issues relating to the autism
controversy." [6]


Background
Education:


1970 - B.S. George Washington University, Washington, D.C.
1970-1971 - Graduate Student; Department of Human Genetics and
Development, Columbia University, New York, New York
1973 - Ph.D. Genetics, George Washington University, Washington, D.C.
1978 - M.D. George Washington University, Washington, D.C.
Work Experience:


1969-1970 - Research (Student) at the National Institutes for Health,
Bethesda, MD
1970-1971 - NIH Traineeship at Columbia University, Department of
Human Genetics and Development, New York, NY
1971-1973 - Research Geneticist, Laboratory of General and Comparative
Biochemistry, National Institute of Mental Health (NIMH), National
Institutes of Health (NIH), Bethesda, Maryland
1973-1974 - Staff Fellow, Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1974-1978 - On Professional Staff Laboratory of General and
Comparative Biochemistry NIMH, NIH, Bethesda, MD
1978-1979 - Intern and Fellow, Department of Obstetrics and
Gynecology, the Johns Hopkins Hospital, Baltimore, Maryland
1979-1982 - Assistant Professor, Department of Gynecology and
Obstetrics, the Johns Hopkins School of Medicine, Baltimore, MD
1980-1982 - Guest worker Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1981-1984 - Assistant Research Professor, Psychiatry Department,
Uniformed School of the Health Sciences, Bethesda, MD
1988-1994 - Director of Genetics of Maryland Medical Laboratory, Inc.
Baltimore, MD
1989-1994 - Member of the Substance Abuse and Doping Committee and the
Sports Medicine and Science Committee of the United States Bobsled and
Skeleton Federation (Olympic Committee)
Board Certification:


1987 - American Board of Medical Genetics
1993 - Associate Founding Member of the American College of Medical
Genetics
1996 - Board Certified by the American Board of Forensic Examiners
1996 - Diplomate of the American Board of Forensic Medicine
Other Positions:


1980-2003 - Laboratory Director, Molecular Medicine, MD
1980-Present - Co-director of Genetic Consultants, Bethesda, MD
1981-Present - Director of Institute of Immuno-Oncology and Genetics,
MD
1986-Present - President of Genetic Counseling and Research, Inc., T/A
The Genetic Center, Baltimore, MD
1997-Present - President of Genetic Counseling and Research, Inc. T/A
The Ultrasound Institute of Baltimore
1997-Present - President of the Genetic Centers of America
2001 - Host of one hour weekly medical talk show "The Dr. Mark Geier
Show" on KFNX in Phoenix, Arizona, WALE in Provident, Rhode Island,
and on the World Wide Web.
Journal Peer-Reviewer:


Annals of Internal Medicine
Clinical and Experimental Rheumatology
Environmental Health Perspectives
Expert Review of Vaccines
Expert Opinion on Emerging Drugs
Vaccine
Major Presentations:


Addressed United States' State Department, Foreign Service Institute
(Washington, DC) on Contemporary Genetics
Addressed the Institute of Medicine of the U.S. National Academy of
Sciences (Washington, DC) on Vaccine Safety & Vaccine Policy Issues
Addressed the Government Reform Committee of the United States' House
of Representatives (Washington, DC) on Vaccine Safety Issues
Addressed the Food and Drug Administration's Vaccine Advisory
Committee (Silver Spring, MD) on Vaccine Safety Issues


See also
Controversies in autism
Vaccination critics


References
JPandS.org (pdf) - 'Thimerosal in Childhood Vaccines, Neurodevelopment
Disorders and Heart Disease in the United States', Mark and David
Geier, Journal of American Physicians and Surgeons, vol 8, no 1,
Spring, 2003
JPandS.org (pdf) - 'A Case-Control Study of Mercury Burden in Children
with Autistic Spectrum Disorders', Jeff Bradstreet, MD, David A.
Geier, BA, Jerold J. Kartzinel, MD, James B. Adams, PhD, Mark R.
Geier, MD, PhD Journal of American Physicians and Surgeons, vol 8, no
3, Summer, 2003
MedSciMonit.com (pdf) - 'A two-phased population epidemiological study
of the safety of thimerosal-containing vaccines: a follow up
analysis', David A. Geier and Mark R. Geier, Med Sci Monit, vol 11, no
4, April 1, 2005


External links
IOM.edu - 'Immunization Safety Review: Vaccines and Autism', US
Institute of Medicine (May 17, 2004)
MomsAgainstMercury.org - 'A Shot in the Dark: Doctors Question Flu
Shot Statistics', Kelly O'Meara (2004)
MomsOnAMissionForAutism.org - Letter from Congressman Dave Weldon,
M.D., to the CDC
UniversityOfHealth.net - 'Institute of Medicine Report Stuns
Scientific Community and Parents: Report Says No Evidence Mercury In
Vaccines Related To Epidemic Levels of Autism' (May 20, 2004)

I asked why you believed his study over others. You posted his resume.
Are you just in awe of his credentials so anything he publishes would be
your new religion? Or is there something about the data that he presented
to make it more believable to you than the studies that contradict him?

"Jan Drew" wrote in message
. com...

"Skeptic" wrote in message
news:8CZbg.955332$x96.369049@attbi_s72...

"Jan Drew" wrote in message
t...

"Skeptic" wrote in message
news:RdMbg.157689$oL.52564@attbi_s71...

"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert,
Gorski, etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.

Why do you find his studies more believable than the studies that
contradict him?


Here are other viewpoints on the work of Dr. Geier ...

So I will extend the same question to you as I did to Ilena - why do you
find the studies by Geier more believable the studies that contradict his
work? Do you give the criticism of his most discussed study any
weight... that he had incorrect facts, that his study design was poor,
and that his conclusions were inaccurate? Or do you just ignore these or
shrug them off?

http://www.answers.com/topic/mark-geier


Mark Geier


Mark R. Geier, MD, PhD, (b. 1948, Washington, D.C.) is a medical
doctor based in Silver Spring, Maryland, who also holds a doctorate in
genetics and is board-certified in medical genetics and forensic
medicine. He was a researcher at the National Institutes of Health for
ten years and previously was a professor at Johns Hopkins University.
He has studied vaccines for more than 30 years and has published over
50 peer-reviewed papers on vaccine safety, efficacy, contamination and
policy. In 1970, while at the National Institutes of Health, Dr. Geier
co-authored a paper published in Nature reporting the first sucessful
genetic engineering experiment in which bacteriophage Lambda which
carried the galactose operon was used to correct the inability of
cells in tissue culture from a patient with galactosemia to metabolise
the milk sugar galactose. This work received world-wide aclaim in the
scientific press and in the news media and resulted in a personal call
of congratulation from then President Richard Nixon. In 1973 Dr. Geier
was an author of another paper in the Nature which reported the
spleen, which was thought to be mostly vestigual in humans, in fact
played a critical role in immunity by maintaining intact antigen
allowing for a more robust immune response which was especially
important the vaccination process. Dr Geier was a co-author on a paper
in the New England Journal of Medicine which futher discussed and
extended the observations on the critical role that the spleen plays
in response to vaccines and other immune challenges. In 1973, Dr.
Geier after having been part of the group that discovered that there
was widespread bacterial virus contamination in US vaccines, presented
a paper "A model system for the evaluation of the fate of phage in
contaminated vaccines: Physiologic disposition of bacteriophage in
mice." at the Proceedings of the Workshop of Problems of Phage
Contamination FDA. In 1978 Dr. Geier published a study "Endotoxins in
commercial vaccine." in Applied and Environmental Microbiology which
found high levels of endotoxin in commercial vaccines especailly in
whole cell Diptheria, Tetanus, Pertussis (DTP) vaccine. Following this
paper, Dr. Geier worked for many years to help convince the public
health authorities to switch from whole cell DTP to the much safer
DTaP which contained a highly purified form of Pertussis vaccine. In
1991 the Institute of Medicine of the National Academy of
Sciences,(IOM) invited Dr. Geier to address them on the toxins
contained in DTP vaccine and the expected time frame over which they
could be expected to work. Dr. Geier presented evidence to the IOM
that the expected time of vulnerability was seven days. In 1993 the
IOM published that the evidence was compatible whole Pertussis vaccine
causing permanent brain damage in otherwise apparently health children
if the first symptoms of neurological damage occurred in the first
seven days following the vaccination. The US began to switch to the
far safer DTaP in 1993 and as of 2002 the US no longer used any whole
cell DTP vaccine.


Career
Dr. Geier wrote the article, The True Story of Pertussis Vaccination:
A Sordid Legacy? which won the first annual Stanley W. Jackson award
for the best paper published in the Journal of the History of Medicine
and Allied Sciences during the period of 2000 to 2002. He has authored
over 90 publications.


Geier has made several presentations to the Institute of Medicine
(IOM) on the adverse effects of vaccinations. He and his son, David
Geier, are the only independent researchers ever to have been
permitted to study the Vaccine Safety Datalink (VSD) database of the
Centers for Disease Control (CDC).


Geier has testified before the US House of Representatives Committee
on Government Reform Investigating Vaccines and the Autism Epidemic,
to critique the Hviid study, conducted in Denmark on autism and
thimerosal exposure, and he has also addressed the Food and Drug
Administration (FDA) Advisory Committee regarding vaccine safety. He
has testified as an expert witness in about 100 cases before the
National Vaccine Injury Compensation Program in the US Court of
Federal Claims. Dr. Geier and his son have been invited to speak to
many state houses who were or are considering state wide bans on
Thimerosal containing vaccines.


Geier has published several scientific reports, with his son David
Geier, showing a relation between mercury exposure during infancy and
the onset of neurodevelopmental disorders. Geier has suggested his
research shows a direct causal link between Thimerosal containing
vaccines (TCVs) and the onset of neurological disorders, including
autism.


Controversial studies
Geier and his son have published six studies on the possible link
between autistic spectrum disorders and TCVs. In their first study,
they compared the number of complaints associated with TCVs,
administered between 1992 and 2000, to the number of complaints
resulting from a thimerosal-free vaccine administered between 1997 and
2000. The children who received greater amounts of ethylmercury from
TCVs were more likely to have a complaint filed with the Vaccine
Adverse Event Reporting System (VAERS). Further studies by the Geiers
yielded similar results.


US health agencies have uniformly rejected the conclusions of the
Geiers' studies, and one of the Geiers' articles was the subject of
heavy criticism by the American Academy of Pediatrics On the other
hand, Mercury in Medicine Taking Unnecessary Risks, a report prepared
by the staff of the Subcommittee on Human Rights and Wellness,
Committee on Government Reform United States House of Representatives
Chaired by Dan Burton published in the Congression Register in May of
2003 stated: However, the Committee upon a thorough review of the
scientific literature and internal documents from government and
industry did find evidence that thimerosal did pose a risk. Thimerosal
used as a preservative in vaccines is likely related to the autism
epidemic. This epidemic in all probability may have been prevented or
curtailed had the FDA not been asleep at the switch regarding the lack
of safety data regarding injected thimerosal and the sharp rise of
infant exposure to this known neurotoxin. Our public health agencies'
failure to act is indicative of institutional malfeasance for
self-protection and misplaced protectionism of the pharmaceutical
industry." [1]. Geier says public health officials are "just trying to
cover it up."


Limited access to Vaccine Safety Datalink records
On February 17, 2004, a panel of medical experts was assembled by the
Institute of Medicine (IOM), an arm of the National Academy of
Sciences. The panel recommended the CDC ease its restrictions on
outside scientists seeking access to its strictly confidential Vaccine
Safety Datalink, containing over seven million records including
reports of suspected adverse reactions to vaccines.


The Geiers have been granted access to this data [2], but the National
Immunization Program found that "In summary, during the first visit
the researchers conducted unapproved analysis on their datasets and on
the second visit attempted to carry out unapproved analyses but did
not complete this attempt. This analysis, had it been completed, could
have increased the risk of a confidentiality breach. Before leaving,
the researchers renamed files for removal which were not allowed to be
removed. Had it gone undetected, this would have constituted a breach
of the rules about confidentiality."[3]


Chelation research
Geier has also published studies which, he says, indicate children
diagnosed with autism excrete more mercury upon chelation than control
subjects. Many of these children are reported as having tests showing
amounts of mercury excreted several times the normal levels. Chelation
therapy is conventionally used only to treat heavy metal poisoning,
and carries the risk of overly reducing the levels of beneficial
metals in the body, such as calcium. In 2004 Dr. Geier and his son
published a paper in Medical Hypotheses, a non-peer-reviewed journal,
on the potential importance of lowering testosterone as part of the
treatment of autism spectum disorders and other disorders which they
claim involve mercury toxicity.


An advocate for vaccine safety
Geier has supported efforts by Representatives Dave Weldon, MD, Dan
Burton, and Carolyn Maloney, to pass legislation introduced in early
2005 to ban the use of mercury based preservatives (i.e., thimerosal)
in vaccines in the United States. Although mercury preservatives have
been removed or reduced from some vaccines in the US, several vaccines
and most US influenza vaccines still contain the full dose of
Thimerosal. Geier said in an interview that the link between
thimerosal and autism was clear.


An NBC crew filmed a presentation by the Geiers before the network's
Autism: The Hidden Epidemic?[4] series in February, 2005, but the
producers chose not to use the material.


Credibility as expert witness questioned
Geier and his son David also serve regularly as expert witnesses for
parents seeking compensation from the National Vaccine Injury
Compensation Program for vaccine injuries to their children. Geier has
been criticized over his qualifications in these hearings, wherein one
Special Master labeled him "a professional witness" who "clearly lacks
the expertise" required. [5] Critics of the vaccine injury
compensation system question the stringency of the requirements, which
they contend effectively preclude fair presentation in the hearings of
testimony from their experts.


On at least ten separate occasions, the Special Master ruled that
Geier lacked the necessary qualifications or board-certification to
offer an expert opinion. Litigants pressing vaccine injury claims have
a dual challenge, since relatively few experts in relevant fields
think thimerosal causes autism, and even fewer work in specialties
required by the Vaccine Injury Compensation Program.


However, on November 25, 2003, Special Master French praised Geier's
credentials and vast experience and said Dr. Geier "ranks high among
those who have studied vaccine issues through the medical literature
on vaccines, databases, studies, articles and information on vaccine
safety and efficacy in vaccine policy. The tenor of his testimony in
this case addressed the importance of statistical databases in
providing statistical reliability and validity in interpreting the
epidemiology and issues relating to autism and various vaccines...Dr.
Geier has recently proposed a data-sharing process that would improve
the reliability of present statistical data that would include the
present VAERS statistical database. It would be helpful in
interpreting the epidemiology and issues relating to the autism
controversy." [6]


Background
Education:


1970 - B.S. George Washington University, Washington, D.C.
1970-1971 - Graduate Student; Department of Human Genetics and
Development, Columbia University, New York, New York
1973 - Ph.D. Genetics, George Washington University, Washington, D.C.
1978 - M.D. George Washington University, Washington, D.C.
Work Experience:


1969-1970 - Research (Student) at the National Institutes for Health,
Bethesda, MD
1970-1971 - NIH Traineeship at Columbia University, Department of
Human Genetics and Development, New York, NY
1971-1973 - Research Geneticist, Laboratory of General and Comparative
Biochemistry, National Institute of Mental Health (NIMH), National
Institutes of Health (NIH), Bethesda, Maryland
1973-1974 - Staff Fellow, Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1974-1978 - On Professional Staff Laboratory of General and
Comparative Biochemistry NIMH, NIH, Bethesda, MD
1978-1979 - Intern and Fellow, Department of Obstetrics and
Gynecology, the Johns Hopkins Hospital, Baltimore, Maryland
1979-1982 - Assistant Professor, Department of Gynecology and
Obstetrics, the Johns Hopkins School of Medicine, Baltimore, MD
1980-1982 - Guest worker Laboratory of General and Comparative
Biochemistry, NIMH, NIH, Bethesda, MD
1981-1984 - Assistant Research Professor, Psychiatry Department,
Uniformed School of the Health Sciences, Bethesda, MD
1988-1994 - Director of Genetics of Maryland Medical Laboratory, Inc.
Baltimore, MD
1989-1994 - Member of the Substance Abuse and Doping Committee and the
Sports Medicine and Science Committee of the United States Bobsled and
Skeleton Federation (Olympic Committee)
Board Certification:


1987 - American Board of Medical Genetics
1993 - Associate Founding Member of the American College of Medical
Genetics
1996 - Board Certified by the American Board of Forensic Examiners
1996 - Diplomate of the American Board of Forensic Medicine
Other Positions:


1980-2003 - Laboratory Director, Molecular Medicine, MD
1980-Present - Co-director of Genetic Consultants, Bethesda, MD
1981-Present - Director of Institute of Immuno-Oncology and Genetics,
MD
1986-Present - President of Genetic Counseling and Research, Inc., T/A
The Genetic Center, Baltimore, MD
1997-Present - President of Genetic Counseling and Research, Inc. T/A
The Ultrasound Institute of Baltimore
1997-Present - President of the Genetic Centers of America
2001 - Host of one hour weekly medical talk show "The Dr. Mark Geier
Show" on KFNX in Phoenix, Arizona, WALE in Provident, Rhode Island,
and on the World Wide Web.
Journal Peer-Reviewer:


Annals of Internal Medicine
Clinical and Experimental Rheumatology
Environmental Health Perspectives
Expert Review of Vaccines
Expert Opinion on Emerging Drugs
Vaccine
Major Presentations:


Addressed United States' State Department, Foreign Service Institute
(Washington, DC) on Contemporary Genetics
Addressed the Institute of Medicine of the U.S. National Academy of
Sciences (Washington, DC) on Vaccine Safety & Vaccine Policy Issues
Addressed the Government Reform Committee of the United States' House
of Representatives (Washington, DC) on Vaccine Safety Issues
Addressed the Food and Drug Administration's Vaccine Advisory
Committee (Silver Spring, MD) on Vaccine Safety Issues


See also
Controversies in autism
Vaccination critics


References
JPandS.org (pdf) - 'Thimerosal in Childhood Vaccines, Neurodevelopment
Disorders and Heart Disease in the United States', Mark and David
Geier, Journal of American Physicians and Surgeons, vol 8, no 1,
Spring, 2003
JPandS.org (pdf) - 'A Case-Control Study of Mercury Burden in Children
with Autistic Spectrum Disorders', Jeff Bradstreet, MD, David A.
Geier, BA, Jerold J. Kartzinel, MD, James B. Adams, PhD, Mark R.
Geier, MD, PhD Journal of American Physicians and Surgeons, vol 8, no
3, Summer, 2003
MedSciMonit.com (pdf) - 'A two-phased population epidemiological study
of the safety of thimerosal-containing vaccines: a follow up
analysis', David A. Geier and Mark R. Geier, Med Sci Monit, vol 11, no
4, April 1, 2005


External links
IOM.edu - 'Immunization Safety Review: Vaccines and Autism', US
Institute of Medicine (May 17, 2004)
MomsAgainstMercury.org - 'A Shot in the Dark: Doctors Question Flu
Shot Statistics', Kelly O'Meara (2004)
MomsOnAMissionForAutism.org - Letter from Congressman Dave Weldon,
M.D., to the CDC
UniversityOfHealth.net - 'Institute of Medicine Report Stuns
Scientific Community and Parents: Report Says No Evidence Mercury In
Vaccines Related To Epidemic Levels of Autism' (May 20, 2004)

Jan Drew wrote:
"Skeptic" wrote in message
news:RdMbg.157689$oL.52564@attbi_s71...
"Ilena Rose" llena Rose wrote in message
.. .
(please don't believe the lies of the Quack Ratbags Team (Probert,
Gorski, etc.)

Dr. Mark R. Geier, MD, PhD. and David A. Geier

Dr. Mark R. Geier, M.D., Ph.D. is a geneticist and President of the
Genetic Centers of America, which for the past 23 years has offered
clinical prenatal genetics services to the Northern Virginia,
Washington, D.C., and Baltimore areas. Dr. Geier has worked in the
fields of molecular and cell biology and genetic engineering at the
National Institutes of Health for ten years. Dr. Geier has also been a
professor at The Johns Hopkins University Hospital.


David A. Geier is president of MedCon, Inc. He graduated with honors
from UMBC with a B.A. in Biology and a minor in History. He has been a
researcher scientist at the National Institutes of Health. Presently,
he is a graduate student in biochemistry at the George Washington
University, and has co-authored over 30 peer-reviewed
scientific/medical publications on vaccine safety, efficacy, and
policy. He has addressed numerous professional meetings, and most
recently co-addressed the Institute of Medicine of the United States'
National Academy of Sciences on vaccines.


In this interview, Mark & David discuss their work with treating heavy
metal toxicity by first treating abnormally high testosterone levels
(responsible for precocious puberty) with Lupron (prior to chelation).
They've found that testosterone actually binds to mercury, increasing
its toxicity and keeping it in the body. This offers compelling reason
for why more boys have autism than girls.
Why do you find his studies more believable than the studies that
contradict him?


Here are other viewpoints on the work of Dr. Geier ...

We are not talking "viewpoints" which are merely opinions. Orac posted
links to well documented analyses of Geier's recent work which
demonstrate that he used inappropriate datasets and incorrect
statistical analysis to reach his conclusions.

Please find some rebuttal of those two well documented arguments about
Geier's work.

Opinions deleted as non-responsive to the discussion.

Mark Probert wrote:
We are not talking "viewpoints" which are merely opinions. Orac posted
links to well documented analyses of Geier's recent work which
demonstrate that he used inappropriate datasets and incorrect
statistical analysis to reach his conclusions.

Please find some rebuttal of those two well documented arguments about
Geier's work.

Opinions deleted as non-responsive to the discussion.

I just tried to post this question above, but Google gave me an error
message. I'll try it here again:

I've seen you make these claims many times. I'm curious to know which
datasets are in question and what subject you're talking about.

Max.

"Max C." wrote in message
oups.com...
Mark Probert wrote:
We are not talking "viewpoints" which are merely opinions. Orac posted
links to well documented analyses of Geier's recent work which
demonstrate that he used inappropriate datasets and incorrect
statistical analysis to reach his conclusions.

Please find some rebuttal of those two well documented arguments about
Geier's work.

Opinions deleted as non-responsive to the discussion.

I just tried to post this question above, but Google gave me an error
message. I'll try it here again:

I've seen you make these claims many times. I'm curious to know which
datasets are in question and what subject you're talking about.

A far more interesting question is this - for those who believe his study,
why is that one so easy to believe even in face of the multitude of
criticisms it received for being incaccurate, flawed, poorly designed,
etc.... all the while not believing other studies that showed contradictory
results. I have yet to see or hear an argument from anyone anywhere that
supports his work over others. Yet some people choose to believe his study.
Why?